Last reviewed · How we verify
Chemotherapy and target therapy — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
Chemotherapy and target therapy (Chemotherapy and target therapy) — Haining Health-Coming Biotech Co., Ltd..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Chemotherapy and target therapy TARGET | Chemotherapy and target therapy | Haining Health-Coming Biotech Co., Ltd. | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Chemotherapy and target therapy CI watch — RSS
- Chemotherapy and target therapy CI watch — Atom
- Chemotherapy and target therapy CI watch — JSON
- Chemotherapy and target therapy alone — RSS
Cite this brief
Drug Landscape (2026). Chemotherapy and target therapy — Competitive Intelligence Brief. https://druglandscape.com/ci/chemotherapy-and-target-therapy. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab